We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.31%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.17B
AUM Growth
+$808M
Cap. Flow
+$417M
Cap. Flow %
8.07%
Top 10 Hldgs %
16.85%
Holding
722
New
51
Increased
415
Reduced
155
Closed
32

Sector Composition

Rank Sector Weight
1 Healthcare 24.05%
2 Financials 13.76%
3 Technology 12.91%
4 Communication Services 9.31%
5 Industrials 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.8T
$113M 2.19%
3,154,376
+432,904
+16% +$14.3M
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.3T
$110M 2.13%
2,594,720
-282,960
-10% -$11.9M
GILD icon
3
Gilead Sciences
GILD
$165B
$103M 2%
1,518,568
+580,801
+62% +$40.8M
CELG
4
DELISTED
Celgene Corp
CELG
$91.2M 1.77%
733,119
+365,647
+100% +$43.8M
AMGN icon
5
Amgen
AMGN
$197B
$86.7M 1.68%
528,562
-182,763
-26% -$30.4M
META icon
6
Meta Platforms (Facebook)
META
$1.64T
$78.6M 1.52%
553,421
+114,103
+26% +$15.2M
XOM icon
7
ExxonMobil
XOM
$615B
$77.4M 1.5%
944,188
+277,348
+42% +$23.2M
AMZN icon
8
Amazon
AMZN
$2.69T
$75.3M 1.46%
1,697,820
+278,000
+20% +$11.6M
MSFT icon
9
Microsoft
MSFT
$2.99T
$68.4M 1.33%
1,039,183
+193,691
+23% +$12.4M
REGN icon
10
Regeneron Pharmaceuticals
REGN
$70.5B
$66.2M 1.28%
170,723
+62,878
+58% +$23.3M
JNJ icon
11
Johnson & Johnson
JNJ
$599B
$64.6M 1.25%
518,804
-444,987
-46% -$53.2M
GE icon
12
GE Aerospace
GE
$354B
$64.1M 1.24%
448,936
+257,651
+135% +$37.3M
PEP icon
13
PepsiCo
PEP
$185B
$57.6M 1.12%
515,319
-143,276
-22% -$15.4M
T icon
14
AT&T
T
$153B
$49.6M 0.96%
1,581,605
+145,918
+10% +$4.59M
BIIB icon
15
Biogen
BIIB
$29.5B
$47.8M 0.93%
174,958
-7,596
-4% -$2.15M
JPM icon
16
JPMorgan Chase
JPM
$901B
$46.4M 0.9%
528,553
+36,366
+7% +$3.21M
INCY icon
17
Incyte
INCY
$23.1B
$45.8M 0.89%
342,356
-21,468
-6% -$2.73M
DIS icon
18
Walt Disney
DIS
$167B
$44.1M 0.85%
388,843
+75,117
+24% +$8.27M
ORCL icon
19
Oracle
ORCL
$350B
$43.1M 0.83%
966,545
+163,113
+20% +$6.79M
VZ icon
20
Verizon
VZ
$182B
$40.4M 0.78%
829,536
+74,253
+10% +$3.73M
AXP icon
21
American Express
AXP
$240B
$36.3M 0.7%
458,350
-3,990
-0.9% -$312K
BABA icon
22
Alibaba
BABA
$288B
$35.7M 0.69%
331,438
+27,480
+9% +$2.8M
CMI icon
23
Cummins
CMI
$88.2B
$34.7M 0.67%
229,473
+32,828
+17% +$4.86M
MCHP icon
24
Microchip Technology
MCHP
$43.7B
$34.2M 0.66%
926,338
+360,562
+64% +$12.7M
HCA icon
25
HCA Healthcare
HCA
$82.2B
$32.1M 0.62%
360,550
+155,639
+76% +$13M

Similar funds

Candriam SCA's Q1 2017 Portfolio in Review

As of Q1 2017, Candriam SCA held 722 positions worth $5.17B, up 19% from $4.36B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Candriam SCA deployed $417M of net new capital in Q1 2017, opening 51 new positions and adding to 415 existing holdings. Its largest new stake was Copart: 1,499,296 shares worth $11.6M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $53.2M trimmed.

  • Candriam SCA's largest Q1 2017 buy was Copart: 1,499,296 shares worth $11.6M.
  • Candriam SCA added most to Celgene Corp in Q1 2017, an estimated $43.8M increase.
  • Candriam SCA's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $53.2M.
  • Candriam SCA fully exited TechnipFMC in Q1 2017, selling an estimated $7.64M.
  • Candriam SCA's ten largest holdings make up 17% of its $5.17B portfolio in Q1 2017.
  • Candriam SCA opened 51 new positions and closed 32 in Q1 2017.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $5.17B.

Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.